查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1621348

虾病诊断市场：按套件、疾病和最终用户划分 - 全球预测 2025-2030

Shrimp Disease Diagnostics Market by Kit (Assay Based Kit, Rapid Testing Kit), Disease (Early Mortality Syndrome, Taura Syndrome Virus, White Spot Syndrome Virus), End User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 187 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年虾病诊断市值为4.4318亿美元，预计2024年将达到4.781亿美元，复合年增长率为7.92%，预计到2030年将达到7.5583亿美元。

调查方法范围涵盖各种旨在识别虾类疾病的诊断工具和技术，这对于维持虾类健康和永续水产养殖至关重要。全球对虾的需求不断增长以及水产养殖业的相应增长推动了对此类诊断的需求，水产养殖业的疾病爆发导致重大经济损失和供应链中断。虾子的疾病诊断应用包括白斑症候群、传染性皮下脂肪变性和造血坏死病毒等疾病的早期检测和预防。最终用途主要包括养鱼场、水生兽医院和诊断实验室。主要市场成长要素包括水产养殖业的快速成长、诊断工具的技术进步以及对永续水产养殖需求的认识不断提高。开发具有成本效益、反应灵敏的诊断工具是有机会的，这些工具在现场条件下很容易获得。另一种可能性是将人工智慧和机器学习等数位技术整合到诊断中，从而实现预测分析和改进的疾病管理策略。

主要市场统计
基准年[2023] 44318万美元
预计年份 [2024] 4.781 亿美元
预测年份 [2030] 75583万美元
复合年增长率（%） 7.92%

然而，先进诊断工具的高成本、新兴市场缺乏基础设施以及监管挑战等限制因素可能会阻碍市场成长。该行业还面临实现标准化诊断程序和确保结果准确可靠的挑战。需要创新和研究的领域包括开发低成本携带式诊断试剂套件、改进生物感测器技术以及探索抗病基因解决方案。投资学术机构和产业参与者之间的研究伙伴关係可以带来抗病虾品种的突破性发现。市场竞争是温和的，因此企业必须不断创新才能保持竞争力。公司应专注于扩大其地理覆盖范围，可能瞄准水产养殖正在成长的新兴市场。此外，透过强调永续和环保的解决方案，我们可以回应消费者对环保生产实践日益增长的兴趣。

市场动态：揭示快速发展的虾病诊断市场的关键市场洞察

供需的动态交互作用正在改变虾病诊断市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时消费行为及其对製造成本的影响以及对采购趋势的影响。

  • 市场驱动因素
    • 扩大世界各地的虾子生产和出口活动
    • 应对虾病的公共和私人意识提升倡议和福利计划
    • 对虾养殖的品质监管和高效疾病检测工具的需求
  • 市场限制因素
    • 复杂的测试程序和需要训练的人员
  • 市场机会
    • 虾子诊断技术和快速检测方法的进展
    • 新投资扩大虾类养殖活动
  • 市场挑战
    • 虾子病诊断中与假阳性和不准确相关的局限性

波特的五力虾子策略工具引领疾病诊断市场

波特的五力框架是了解虾子病诊断市场竞争格局的关键工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解虾子病诊断市场的外部影响

外部宏观环境因素在塑造虾病诊断市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析 了解虾子病诊断市场的竞争状况

对虾病诊断市场的详细市场占有率分析可以对供应商的表现进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵虾病诊断市场供应商的绩效评估

FPNV定位矩阵是评估虾子病诊断市场供应商的关键工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议，以规划虾病诊断市场的成功之路

对虾病诊断市场的策略分析对于旨在加强其在全球市场的影响力的公司至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：详细检视当前市场环境、主要企业的广泛资料、评估其在市场中的影响力和整体影响力。

2. 市场开发：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、未开发地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 世界各地的虾子生产和出口不断扩大
      • 应对虾病的公共和私人意识活动和福利计划
      • 高品质对虾养殖需要法规和有效的疾病检测工具
    • 抑制因素
      • 复杂的测试程序和需要训练的人员
    • 机会
      • 虾子诊断技术和快速检测方法的进展
      • 新投资扩大虾类养殖活动
    • 任务
      • 虾子病诊断中与假阳性和不准确相关的局限性
  • 市场区隔分析
    • 套件：更多采用快速检测套组来快速、轻鬆地检测病原体
    • 疾病：白斑症病毒 (WSSV) 具有高度传染性，需要高品质的 PCR 和组织学检测。
    • 最终用户：渔业中虾病发病率的增加需要部署虾病诊断策略
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章 虾病诊断市场试剂套件

  • 检测基础套件
  • 快速检测套组

第七章虾病诊断市场：依疾病分类

  • 早死综合症
  • 桃拉症候群病毒
  • 白癜风症候群病毒
  • 黄头或鳃相关病毒

第八章虾病诊断市场：依最终用户分类

  • 水产养殖与海洋研究所
  • 教育及研究机构
  • 钓鱼

第九章 北美和南美虾病诊断市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十章亚太地区虾病诊断市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十一章 欧洲、中东和非洲虾病诊断市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十二章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
    • 美国计划为虾农开发低成本白斑症测试
    • ViAqua Therapeutics 获得基于 RNA 的水产养殖疾病管理资金
    • Aquatrek 签署研究协议，为养鱼场开发诊断服务
  • 战略分析和建议

公司名单

  • 3 Little Fish Sdn Bhd
  • Amazing Biotech
  • Aquaintech Inc.
  • Arachem（M）Sdn Bhd
  • Bioneer Corporation
  • Blue Aqua International Pte. Ltd.
  • CD Genomics
  • China Guangzhou BioKey Healthy Technology Co. Ltd
  • DSM Austria GmbH
  • Forte Biotech
  • GeneReach Biotechnology Corp.
  • GeneReach Biotechnology Corporation
  • Genics Pty. Ltd.
  • Illumina, Inc.
  • Innocreate Bioscience Co., Ltd.
  • Lab-Ind Resource Sdn. Bhd.
  • Laboratory Corporation of America Holdings
  • Mahesh Aqua Holdings（Pvt）Ltd.
  • Mylab Discovery Solutions Pvt. Ltd.
  • PT Riset Nusantara Genetika（Nusantics）
  • Randox Laboratories Ltd.
  • Reagen LLC
  • Ring Biotechnology Co Ltd.
  • Speedy Assay Sdn. Bhd.
  • SUREBIO
  • Thermo Fisher Scientific Inc.
Product Code: MRR-03023C19E52A

The Shrimp Disease Diagnostics Market was valued at USD 443.18 million in 2023, expected to reach USD 478.10 million in 2024, and is projected to grow at a CAGR of 7.92%, to USD 755.83 million by 2030.

The scope of the shrimp disease diagnostics market covers a range of diagnostic tools and methodologies designed to identify diseases in shrimp populations, vital to maintaining shrimp health and ensuring sustainable aquaculture practices. The necessity of these diagnostics arises from the increasing global demand for shrimp and the corresponding rise in aquaculture, where disease outbreaks can lead to significant economic losses and supply chain disruptions. Applications of shrimp disease diagnostics include early detection and prevention of diseases like white spot syndrome, infectious hypodermal and hematopoietic necrosis virus, among others. End-use scope primarily includes aquaculture farms, veterinary clinics specializing in aquatic creatures, and diagnostic laboratories. Key market growth factors include the burgeoning aquaculture industry, technological advancements in diagnostic tools, and increased awareness of the need for sustainable aqua farming practices. Opportunities lie in developing cost-effective, quick-response diagnostic tools that can be easily utilized in field conditions. Another potential opportunity is the integration of digital technologies such as AI and machine learning in diagnostics, allowing for predictive analytics and improved disease management strategies.

KEY MARKET STATISTICS
Base Year [2023] USD 443.18 million
Estimated Year [2024] USD 478.10 million
Forecast Year [2030] USD 755.83 million
CAGR (%) 7.92%

However, limitations such as high costs associated with advanced diagnostic tools, lack of infrastructure in developing regions, and regulatory challenges could impede market growth. The industry also faces challenges in achieving standardized diagnostic procedures and ensuring accuracy and reliability outcomes. Areas ripe for innovation and research include developing low-cost portable diagnostic kits, improving biosensor technology, and exploring genetic solutions for disease resistance. Investing in research partnerships between academic institutions and industry players could foster breakthroughs in disease-resistant shrimp strains. The market is characterized by moderate competition, requiring players to continuously innovate to maintain a competitive edge. Companies should focus on expanding their geographic reach, possibly targeting emerging markets with growing aquaculture activities. Emphasizing sustainable and eco-friendly solutions will also cater to the increasing consumer focus on environmentally responsible production practices.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Shrimp Disease Diagnostics Market

The Shrimp Disease Diagnostics Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Growing shrimp production and export activities worldwide
    • Public-private awareness initiatives and welfare projects to tackle shrimp diseases
    • Regulations for quality shrimp farming and need for efficient disease detection tools
  • Market Restraints
    • Complex testing procedures and need for trained personnel
  • Market Opportunities
    • Advancements in shrimp diagnostics technologies and rapid testing methods
    • New investments in expansion of shrimp farming activities
  • Market Challenges
    • Limitations associated with false positives and inaccuracy of shrimp disease diagnostics

Porter's Five Forces: A Strategic Tool for Navigating the Shrimp Disease Diagnostics Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Shrimp Disease Diagnostics Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Shrimp Disease Diagnostics Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Shrimp Disease Diagnostics Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Shrimp Disease Diagnostics Market

A detailed market share analysis in the Shrimp Disease Diagnostics Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Shrimp Disease Diagnostics Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Shrimp Disease Diagnostics Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Shrimp Disease Diagnostics Market

A strategic analysis of the Shrimp Disease Diagnostics Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Shrimp Disease Diagnostics Market, highlighting leading vendors and their innovative profiles. These include 3 Little Fish Sdn Bhd, Amazing Biotech, Aquaintech Inc., Arachem (M) Sdn Bhd, Bioneer Corporation, Blue Aqua International Pte. Ltd., CD Genomics, China Guangzhou BioKey Healthy Technology Co. Ltd, DSM Austria GmbH, Forte Biotech, GeneReach Biotechnology Corp., GeneReach Biotechnology Corporation, Genics Pty. Ltd., Illumina, Inc., Innocreate Bioscience Co., Ltd., Lab-Ind Resource Sdn. Bhd., Laboratory Corporation of America Holdings, Mahesh Aqua Holdings (Pvt) Ltd., Mylab Discovery Solutions Pvt. Ltd., PT Riset Nusantara Genetika (Nusantics), Randox Laboratories Ltd., Reagen LLC, Ring Biotechnology Co Ltd., Speedy Assay Sdn. Bhd., SUREBIO, and Thermo Fisher Scientific Inc..

Market Segmentation & Coverage

This research report categorizes the Shrimp Disease Diagnostics Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Kit, market is studied across Assay Based Kit and Rapid Testing Kit.
  • Based on Disease, market is studied across Early Mortality Syndrome, Taura Syndrome Virus, White Spot Syndrome Virus, and Yellow Head or Gill Associated Virus.
  • Based on End User, market is studied across Aquaculture & Marine Laboratories, Education & Research Institutes, and Fisheries.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing shrimp production and export activities worldwide
      • 5.1.1.2. Public-private awareness initiatives and welfare projects to tackle shrimp diseases
      • 5.1.1.3. Regulations for quality shrimp farming and need for efficient disease detection tools
    • 5.1.2. Restraints
      • 5.1.2.1. Complex testing procedures and need for trained personnel
    • 5.1.3. Opportunities
      • 5.1.3.1. Advancements in shrimp diagnostics technologies and rapid testing methods
      • 5.1.3.2. New investments in expansion of shrimp farming activities
    • 5.1.4. Challenges
      • 5.1.4.1. Limitations associated with false positives and inaccuracy of shrimp disease diagnostics
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Kit: Growing adoption of rapid testing kits for quick and easy detection of pathogens
    • 5.2.2. Disease: Highly contagious nature of white spot syndrome virus (WSSV) necessitating quality PCR and histological tests
    • 5.2.3. End User: Rising incidences of shrimp disease outbreaks in fisheries necessitating deployment of shrimp disease diagnostics strategies
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Shrimp Disease Diagnostics Market, by Kit

  • 6.1. Introduction
  • 6.2. Assay Based Kit
  • 6.3. Rapid Testing Kit

7. Shrimp Disease Diagnostics Market, by Disease

  • 7.1. Introduction
  • 7.2. Early Mortality Syndrome
  • 7.3. Taura Syndrome Virus
  • 7.4. White Spot Syndrome Virus
  • 7.5. Yellow Head or Gill Associated Virus

8. Shrimp Disease Diagnostics Market, by End User

  • 8.1. Introduction
  • 8.2. Aquaculture & Marine Laboratories
  • 8.3. Education & Research Institutes
  • 8.4. Fisheries

9. Americas Shrimp Disease Diagnostics Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Shrimp Disease Diagnostics Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Shrimp Disease Diagnostics Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
    • 12.3.1. US Project to Develop Low-Cost White Spot Test for Shrimp Farmers
    • 12.3.2. ViAqua Therapeutics Secures Funding for RNA-based Aquaculture Disease Management
    • 12.3.3. Aquatreck Signs Research Agreement to Develop Diagnostic Services for Fish Farms
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. 3 Little Fish Sdn Bhd
  • 2. Amazing Biotech
  • 3. Aquaintech Inc.
  • 4. Arachem (M) Sdn Bhd
  • 5. Bioneer Corporation
  • 6. Blue Aqua International Pte. Ltd.
  • 7. CD Genomics
  • 8. China Guangzhou BioKey Healthy Technology Co. Ltd
  • 9. DSM Austria GmbH
  • 10. Forte Biotech
  • 11. GeneReach Biotechnology Corp.
  • 12. GeneReach Biotechnology Corporation
  • 13. Genics Pty. Ltd.
  • 14. Illumina, Inc.
  • 15. Innocreate Bioscience Co., Ltd.
  • 16. Lab-Ind Resource Sdn. Bhd.
  • 17. Laboratory Corporation of America Holdings
  • 18. Mahesh Aqua Holdings (Pvt) Ltd.
  • 19. Mylab Discovery Solutions Pvt. Ltd.
  • 20. PT Riset Nusantara Genetika (Nusantics)
  • 21. Randox Laboratories Ltd.
  • 22. Reagen LLC
  • 23. Ring Biotechnology Co Ltd.
  • 24. Speedy Assay Sdn. Bhd.
  • 25. SUREBIO
  • 26. Thermo Fisher Scientific Inc.

LIST OF FIGURES

  • FIGURE 1. SHRIMP DISEASE DIAGNOSTICS MARKET RESEARCH PROCESS
  • FIGURE 2. SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY KIT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY KIT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. SHRIMP DISEASE DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. SHRIMP DISEASE DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. SHRIMP DISEASE DIAGNOSTICS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. SHRIMP DISEASE DIAGNOSTICS MARKET DYNAMICS
  • TABLE 7. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY KIT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY ASSAY BASED KIT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY RAPID TESTING KIT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY EARLY MORTALITY SYNDROME, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY TAURA SYNDROME VIRUS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY WHITE SPOT SYNDROME VIRUS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY YELLOW HEAD OR GILL ASSOCIATED VIRUS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY AQUACULTURE & MARINE LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY EDUCATION & RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY FISHERIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY KIT, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 23. ARGENTINA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY KIT, 2018-2030 (USD MILLION)
  • TABLE 24. ARGENTINA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 25. ARGENTINA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 26. BRAZIL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY KIT, 2018-2030 (USD MILLION)
  • TABLE 27. BRAZIL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 28. BRAZIL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 29. CANADA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY KIT, 2018-2030 (USD MILLION)
  • TABLE 30. CANADA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 31. CANADA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 32. MEXICO SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY KIT, 2018-2030 (USD MILLION)
  • TABLE 33. MEXICO SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 34. MEXICO SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 35. UNITED STATES SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY KIT, 2018-2030 (USD MILLION)
  • TABLE 36. UNITED STATES SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 37. UNITED STATES SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 38. UNITED STATES SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 39. ASIA-PACIFIC SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY KIT, 2018-2030 (USD MILLION)
  • TABLE 40. ASIA-PACIFIC SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 41. ASIA-PACIFIC SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 42. ASIA-PACIFIC SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 43. AUSTRALIA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY KIT, 2018-2030 (USD MILLION)
  • TABLE 44. AUSTRALIA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 45. AUSTRALIA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 46. CHINA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY KIT, 2018-2030 (USD MILLION)
  • TABLE 47. CHINA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 48. CHINA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 49. INDIA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY KIT, 2018-2030 (USD MILLION)
  • TABLE 50. INDIA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 51. INDIA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 52. INDONESIA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY KIT, 2018-2030 (USD MILLION)
  • TABLE 53. INDONESIA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 54. INDONESIA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 55. JAPAN SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY KIT, 2018-2030 (USD MILLION)
  • TABLE 56. JAPAN SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 57. JAPAN SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 58. MALAYSIA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY KIT, 2018-2030 (USD MILLION)
  • TABLE 59. MALAYSIA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 60. MALAYSIA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 61. PHILIPPINES SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY KIT, 2018-2030 (USD MILLION)
  • TABLE 62. PHILIPPINES SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 63. PHILIPPINES SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 64. SINGAPORE SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY KIT, 2018-2030 (USD MILLION)
  • TABLE 65. SINGAPORE SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 66. SINGAPORE SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 67. SOUTH KOREA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY KIT, 2018-2030 (USD MILLION)
  • TABLE 68. SOUTH KOREA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 69. SOUTH KOREA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 70. TAIWAN SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY KIT, 2018-2030 (USD MILLION)
  • TABLE 71. TAIWAN SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 72. TAIWAN SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 73. THAILAND SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY KIT, 2018-2030 (USD MILLION)
  • TABLE 74. THAILAND SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 75. THAILAND SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 76. VIETNAM SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY KIT, 2018-2030 (USD MILLION)
  • TABLE 77. VIETNAM SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 78. VIETNAM SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 79. EUROPE, MIDDLE EAST & AFRICA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY KIT, 2018-2030 (USD MILLION)
  • TABLE 80. EUROPE, MIDDLE EAST & AFRICA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 81. EUROPE, MIDDLE EAST & AFRICA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 82. EUROPE, MIDDLE EAST & AFRICA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 83. DENMARK SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY KIT, 2018-2030 (USD MILLION)
  • TABLE 84. DENMARK SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 85. DENMARK SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 86. EGYPT SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY KIT, 2018-2030 (USD MILLION)
  • TABLE 87. EGYPT SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 88. EGYPT SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 89. FINLAND SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY KIT, 2018-2030 (USD MILLION)
  • TABLE 90. FINLAND SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 91. FINLAND SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 92. FRANCE SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY KIT, 2018-2030 (USD MILLION)
  • TABLE 93. FRANCE SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 94. FRANCE SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 95. GERMANY SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY KIT, 2018-2030 (USD MILLION)
  • TABLE 96. GERMANY SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 97. GERMANY SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 98. ISRAEL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY KIT, 2018-2030 (USD MILLION)
  • TABLE 99. ISRAEL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 100. ISRAEL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 101. ITALY SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY KIT, 2018-2030 (USD MILLION)
  • TABLE 102. ITALY SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 103. ITALY SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 104. NETHERLANDS SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY KIT, 2018-2030 (USD MILLION)
  • TABLE 105. NETHERLANDS SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 106. NETHERLANDS SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 107. NIGERIA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY KIT, 2018-2030 (USD MILLION)
  • TABLE 108. NIGERIA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 109. NIGERIA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 110. NORWAY SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY KIT, 2018-2030 (USD MILLION)
  • TABLE 111. NORWAY SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 112. NORWAY SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 113. POLAND SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY KIT, 2018-2030 (USD MILLION)
  • TABLE 114. POLAND SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 115. POLAND SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 116. QATAR SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY KIT, 2018-2030 (USD MILLION)
  • TABLE 117. QATAR SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 118. QATAR SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 119. RUSSIA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY KIT, 2018-2030 (USD MILLION)
  • TABLE 120. RUSSIA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 121. RUSSIA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 122. SAUDI ARABIA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY KIT, 2018-2030 (USD MILLION)
  • TABLE 123. SAUDI ARABIA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 124. SAUDI ARABIA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 125. SOUTH AFRICA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY KIT, 2018-2030 (USD MILLION)
  • TABLE 126. SOUTH AFRICA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 127. SOUTH AFRICA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 128. SPAIN SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY KIT, 2018-2030 (USD MILLION)
  • TABLE 129. SPAIN SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 130. SPAIN SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 131. SWEDEN SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY KIT, 2018-2030 (USD MILLION)
  • TABLE 132. SWEDEN SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 133. SWEDEN SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 134. SWITZERLAND SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY KIT, 2018-2030 (USD MILLION)
  • TABLE 135. SWITZERLAND SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 136. SWITZERLAND SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 137. TURKEY SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY KIT, 2018-2030 (USD MILLION)
  • TABLE 138. TURKEY SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 139. TURKEY SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 140. UNITED ARAB EMIRATES SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY KIT, 2018-2030 (USD MILLION)
  • TABLE 141. UNITED ARAB EMIRATES SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED ARAB EMIRATES SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED KINGDOM SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY KIT, 2018-2030 (USD MILLION)
  • TABLE 144. UNITED KINGDOM SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 145. UNITED KINGDOM SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 146. SHRIMP DISEASE DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 147. SHRIMP DISEASE DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2023